PL1884234T3 - Środek profilaktyczny lub leczniczy w zaburzeniach rogówkowych i spojówkowych - Google Patents

Środek profilaktyczny lub leczniczy w zaburzeniach rogówkowych i spojówkowych

Info

Publication number
PL1884234T3
PL1884234T3 PL06746500T PL06746500T PL1884234T3 PL 1884234 T3 PL1884234 T3 PL 1884234T3 PL 06746500 T PL06746500 T PL 06746500T PL 06746500 T PL06746500 T PL 06746500T PL 1884234 T3 PL1884234 T3 PL 1884234T3
Authority
PL
Poland
Prior art keywords
corneal
prophylactic
therapeutic agent
conjunctival disorder
conjunctival
Prior art date
Application number
PL06746500T
Other languages
English (en)
Inventor
Shinichirou Hirai
Atsushi Yoshida
Masatsugu Nakamura
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of PL1884234T3 publication Critical patent/PL1884234T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/26—Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL06746500T 2005-05-17 2006-05-17 Środek profilaktyczny lub leczniczy w zaburzeniach rogówkowych i spojówkowych PL1884234T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2005143477 2005-05-17
PCT/JP2006/309797 WO2006123676A1 (ja) 2005-05-17 2006-05-17 角結膜障害の予防または治療剤
EP06746500A EP1884234B1 (en) 2005-05-17 2006-05-17 Prophylactic or therapeutic agent for corneal and conjunctival disorder

Publications (1)

Publication Number Publication Date
PL1884234T3 true PL1884234T3 (pl) 2012-11-30

Family

ID=37431248

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06746500T PL1884234T3 (pl) 2005-05-17 2006-05-17 Środek profilaktyczny lub leczniczy w zaburzeniach rogówkowych i spojówkowych

Country Status (14)

Country Link
US (2) US8222283B2 (pl)
EP (1) EP1884234B1 (pl)
KR (1) KR101286883B1 (pl)
CN (1) CN101175487B (pl)
CA (1) CA2608457C (pl)
CY (1) CY1113161T1 (pl)
DK (1) DK1884234T3 (pl)
ES (1) ES2389566T3 (pl)
NO (1) NO20076398L (pl)
PL (1) PL1884234T3 (pl)
PT (1) PT1884234E (pl)
RU (1) RU2406499C2 (pl)
SI (1) SI1884234T1 (pl)
WO (1) WO2006123676A1 (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8222283B2 (en) 2005-05-17 2012-07-17 Santen Pharmaceutical Co., Ltd. Method for treating a keratoconjunctival disorder
KR20100016140A (ko) 2007-05-25 2010-02-12 산텐 세이야꾸 가부시키가이샤 가령 황반 변성의 예방 또는 치료제
CA2716466A1 (en) * 2008-02-28 2009-09-03 Santen Pharmaceutical Co., Ltd. Prophylactic or therapeutic agent for eye disease accompanied by optic nerve disorder
RU2459615C1 (ru) * 2011-03-05 2012-08-27 Илья Александрович Марков Глазные капли для лечения болезни сухого глаза
CN107550920A (zh) * 2011-11-24 2018-01-09 东洋精糖株式会社 角结膜保护剂或角结膜障碍抑制剂
RU2522381C1 (ru) * 2013-01-24 2014-07-10 федеральное государственное бюджетное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации Способ лечения трофических эрозий роговицы
KR101692578B1 (ko) * 2013-04-18 2017-01-03 삼진제약주식회사 레바미피드 또는 이의 전구체를 포함하는 안구건조증의 예방 또는 치료를 위한 경구용 약제학적 조성물
RU2544225C1 (ru) * 2013-12-13 2015-03-10 федеральное государственное бюджетное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации Способ лечения послеоперационных эрозий роговицы после удаления птеригиума
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
WO2017070637A1 (en) 2015-10-23 2017-04-27 The Trustees Of Columbia University In The City Of New York Laser induced collagen crosslinking in tissue
GB2550110A (en) 2016-04-28 2017-11-15 Univ Oxford Innovation Ltd Treatment of impulsivity-related disorders
US11497403B2 (en) 2016-06-10 2022-11-15 The Trustees Of Columbia University In The City Of New York Devices, methods, and systems for detection of collagen tissue features
EP3668836A4 (en) * 2017-08-18 2021-04-07 The Schepens Eye Research Institute, Inc. DRY EYE TREATMENT COMPOSITIONS AND METHODS OF APPLYING THEREOF
GB201717629D0 (en) 2017-10-26 2017-12-13 Univ Oxford Innovation Ltd Treatment of unipolar depressive disorder
US11666481B1 (en) 2017-12-01 2023-06-06 The Trustees Of Columbia University In The City Of New York Diagnosis and treatment of collagen-containing tissues
EP4536191A1 (en) * 2022-06-06 2025-04-16 Sound Pharmaceuticals Incorporated Ebselen containing oral dosage forms

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3616923A1 (de) * 1986-05-20 1987-11-26 Nattermann A & Cie Neue pharmazeutische verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on
US4778814A (en) * 1987-03-18 1988-10-18 Ciba-Geigy Corporation Method of treating ocular allergy by topical application of a 2-substituted-1,2-benzisoselenazol-3(2H)-one
ES2145065T3 (es) * 1993-10-27 2000-07-01 Daiichi Seiyaku Co Preparacion granular.
CA2224563A1 (en) * 1995-06-12 1996-12-27 G.D. Searle & Co. Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations
FR2740339B1 (fr) * 1995-10-26 1997-12-05 Oreal Utilisation d'au moins un inhibiteur de no-synthase dans le traitement des peaux sensibles
FR2757860B1 (fr) * 1996-12-27 1999-04-23 Oxis International Sa Composes organoselenies cycliques, leur preparation et leurs utilisations, notamment therapeutiques
JP2001261555A (ja) 2000-03-17 2001-09-26 Dai Ichi Seiyaku Co Ltd 脳動脈中膜肥厚抑制剤
FR2815541B1 (fr) * 2000-10-24 2008-02-29 Lipha Utilisation d'inhibiteurs de l'apoptose des pericytes pour le traitement et/ou la prevention de la retinopathie diabetique
US7732487B2 (en) * 2001-11-19 2010-06-08 Sucampo Ag Method for treating a disease or condition responsive to opening of C1C-2 channel
WO2004069157A2 (en) 2003-01-17 2004-08-19 Ophthalmic Research Associates, Inc. Combinational use of long-acting and short-acting anti-histamines for ocular allergies
CA2488143A1 (en) 2003-02-07 2004-08-26 The General Hospital Corporation Methods and compositions for modulating glutamate transport activity in the nervous system
JP2006104199A (ja) 2004-09-13 2006-04-20 Santen Pharmaceut Co Ltd 角結膜障害治療剤
US8222283B2 (en) 2005-05-17 2012-07-17 Santen Pharmaceutical Co., Ltd. Method for treating a keratoconjunctival disorder
JP2008013448A (ja) 2006-07-03 2008-01-24 Gifu Prefecture 視神経細胞保護剤
KR20100016140A (ko) 2007-05-25 2010-02-12 산텐 세이야꾸 가부시키가이샤 가령 황반 변성의 예방 또는 치료제
CA2716466A1 (en) * 2008-02-28 2009-09-03 Santen Pharmaceutical Co., Ltd. Prophylactic or therapeutic agent for eye disease accompanied by optic nerve disorder

Also Published As

Publication number Publication date
EP1884234A4 (en) 2010-01-13
US8222283B2 (en) 2012-07-17
US8536207B2 (en) 2013-09-17
RU2007146688A (ru) 2009-06-27
NO20076398L (no) 2008-02-11
KR101286883B1 (ko) 2013-07-16
CA2608457A1 (en) 2006-11-23
US20090105313A1 (en) 2009-04-23
EP1884234A1 (en) 2008-02-06
KR20080016556A (ko) 2008-02-21
RU2406499C2 (ru) 2010-12-20
CN101175487A (zh) 2008-05-07
EP1884234B1 (en) 2012-07-18
SI1884234T1 (sl) 2012-10-30
US20120232119A1 (en) 2012-09-13
CN101175487B (zh) 2011-11-16
DK1884234T3 (da) 2012-10-08
WO2006123676A1 (ja) 2006-11-23
CY1113161T1 (el) 2016-04-13
ES2389566T3 (es) 2012-10-29
CA2608457C (en) 2013-09-10
PT1884234E (pt) 2012-07-26

Similar Documents

Publication Publication Date Title
TWI369996B (en) Ophthalmic compositions and methods for treating eyes
EP1861161A4 (en) APPARATUS AND METHOD FOR DISPENSING THERAPEUTIC AND / OR OTHER AGENTS IN THE INTERNAL EAR AND OTHER FABRICS
EP1893216A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF EYE DISEASES
SI1881823T1 (sl) Sestavki in postopki za zdravljenje bolezni oäśesa
EP1737482A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES
ZA200709727B (en) Compounds and methods for the treatment of prevention of flavivirus infections
LT2374472T (lt) Kompozicijos ir būdai oftalmologinių sutrikimų gydymui
IL191072A0 (en) Therapeutic compositions and methods
EP1884234A4 (en) PROPHYLACTIC OR THERAPEUTIC AGENT FOR DISEASES OF CORNEAL AND BINDING SKIN
IL189009A0 (en) Methods and compositions for the treatment of neuropathies and related disorders
WO2006121421A8 (en) Methods and formulations for treating glaucoma
GB0521139D0 (en) Therapeutic agent
GB0615545D0 (en) Therapeutic agent
IL183520A0 (en) Preventive or therapeutic agent for sleep disorder
PL1905452T3 (pl) Środek do zapobiegania lub leczenia jaskry
ZA200806881B (en) Therapeutic prophylactic ophthalmologic lens for pseudo-aphakic eyes and/or eyes suffering neurodegeneration
ZA200904328B (en) Prophylactic or therapeutic agent for alopecia
EP1877840A4 (en) OPHTHALMIC APPARATUS AND METHODS
EP1844792A4 (en) THERAPEUTIC AGENT AGAINST OBSTIPATION
EP1894572A4 (en) THERAPEUTIC AND / OR PROPHYLACTIC AGGREGATE AGAINST NEUROGENIC PAIN
EP1859795A4 (en) THERAPEUTIC AGENT FOR OPHTHALMIC DISEASES
PL2374472T3 (pl) Kompozycje i sposoby leczenia zaburzeń okulistycznych
PL1872783T3 (pl) Środek leczniczy w schorzeniach rogówkowo-spojówkowych
GB0508153D0 (en) Therapeutic agent
GB201013152D0 (en) Prophylactic and therapeutic agents and uses thereof